The global uterine cancer therapeutics and diagnostics market was valued at $2.4 billion in 2023, and is projected to reach $5.5 Billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033
Report Code : A324056 | Pages : 280 | Category : Life Sciences
